Log in

NASDAQ:CTRECaretrust REIT Stock Price, Forecast & News

$17.01
-0.24 (-1.39 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$16.82
Now: $17.01
$17.90
50-Day Range
$16.28
MA: $18.49
$20.85
52-Week Range
$7.16
Now: $17.01
$24.65
Volume1.22 million shs
Average Volume1.33 million shs
Market Capitalization$1.63 billion
P/E Ratio32.71
Dividend Yield5.88%
Beta1.03
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.
Read More
Caretrust REIT logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.15 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:CTRE
Previous SymbolNASDAQ:CTREV
CUSIPN/A
Phone949-542-3130

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$163.40 million
Cash Flow$1.09 per share
Book Value$9.71 per share

Profitability

Net Income$46.36 million

Miscellaneous

Employees57
Market Cap$1.63 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive CTRE News and Ratings via Email

Sign-up to receive the latest news and ratings for CTRE and its competitors with MarketBeat's FREE daily newsletter.

Caretrust REIT (NASDAQ:CTRE) Frequently Asked Questions

How has Caretrust REIT's stock been impacted by COVID-19 (Coronavirus)?

Caretrust REIT's stock was trading at $16.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CTRE stock has increased by 0.1% and is now trading at $17.01. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Caretrust REIT?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Caretrust REIT.

When is Caretrust REIT's next earnings date?

Caretrust REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Caretrust REIT.

How were Caretrust REIT's earnings last quarter?

Caretrust REIT Inc (NASDAQ:CTRE) announced its quarterly earnings results on Thursday, May, 7th. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.34 by $0.14. The real estate investment trust earned $44.34 million during the quarter, compared to analysts' expectations of $43.20 million. Caretrust REIT had a return on equity of 5.32% and a net margin of 29.53%. View Caretrust REIT's earnings history.

How often does Caretrust REIT pay dividends? What is the dividend yield for Caretrust REIT?

Caretrust REIT declared a quarterly dividend on Wednesday, June 17th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.25 per share on Wednesday, July 15th. This represents a $1.00 annualized dividend and a yield of 5.88%. The ex-dividend date of this dividend is Monday, June 29th. View Caretrust REIT's dividend history.

What guidance has Caretrust REIT issued on next quarter's earnings?

Caretrust REIT updated its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of 1.32-1.34 for the period.

What price target have analysts set for CTRE?

7 Wall Street analysts have issued 1-year price targets for Caretrust REIT's shares. Their forecasts range from $13.00 to $26.00. On average, they expect Caretrust REIT's stock price to reach $21.43 in the next twelve months. This suggests a possible upside of 26.0% from the stock's current price. View analysts' price targets for Caretrust REIT.

Has Caretrust REIT been receiving favorable news coverage?

News headlines about CTRE stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Caretrust REIT earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave press coverage about the real estate investment trust a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View the latest news about Caretrust REIT.

Are investors shorting Caretrust REIT?

Caretrust REIT saw a increase in short interest in June. As of June 15th, there was short interest totaling 2,140,000 shares, an increase of 27.4% from the May 31st total of 1,680,000 shares. Based on an average daily trading volume, of 952,800 shares, the short-interest ratio is currently 2.2 days. Approximately 2.3% of the shares of the stock are sold short. View Caretrust REIT's Current Options Chain.

Who are some of Caretrust REIT's key competitors?

What other stocks do shareholders of Caretrust REIT own?

Who are Caretrust REIT's key executives?

Caretrust REIT's management team includes the following people:
  • Mr. Gregory K. Stapley J.D., Chairman, Pres & CEO (Age 59)
  • Mr. William M. Wagner, CFO, Treasurer & Sec. (Age 53)
  • Mr. David M. Sedgwick, Chief Operating Officer (Age 43)
  • Mr. Mark D. Lamb, Chief Investment Officer
  • Ms. Lauren Beale, Controller

What is Caretrust REIT's stock symbol?

Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE."

How do I buy shares of Caretrust REIT?

Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Caretrust REIT's stock price today?

One share of CTRE stock can currently be purchased for approximately $17.01.

How big of a company is Caretrust REIT?

Caretrust REIT has a market capitalization of $1.63 billion and generates $163.40 million in revenue each year. The real estate investment trust earns $46.36 million in net income (profit) each year or $1.36 on an earnings per share basis. Caretrust REIT employs 57 workers across the globe.

What is Caretrust REIT's official website?

The official website for Caretrust REIT is www.caretrustreit.com.

How can I contact Caretrust REIT?

Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.